To further verify the bona fide SG induced by chemotherapeutic drugs, OS, glioma and NSCLC cancer cells were co-treated with the SG formation inhibitor ISRIB,28 which reverses the effects that occur downstream of eIF2α phosphorylation. The gene discussed is EIF2A; the disease is central nervous system cancer.